Are Japanese equities experiencing a new dawn?

Equities 6 minutes to read

Peter Garnry

Head of Equity Strategy

Summary:  Japanese equities have undergone a renaissance since late 2012 when Abenomics were introduced. Earnings and corporate efficiency have improved dramatically and while the Covid-19 slowdown has temporarily arrested this trend, we believe Japanese companies will come roaring back in 2021 driven by Chinese growth stimulus, a shift towards pro-cyclical and value segments of the market, but also a shift into equity markets with lower financial leverage. Could Japanese equities finally be seeing a new dawn?


Nikkei 225 futures are up 3% today extending November’s gain to 13.9% and this year’s gain of 10.6% as foreign investors are warming up to Japanese equities. That makes Japanese equities one of the best segments of the global equity market is a surprise move because most investors think of Japan as old and dying with irrelevant brands, at least in the age of technology, such as Sony and Toyota. But Japanese equities are signalling something important to investors that should not be ignored. We are guessing that Japan could rise like a phoenix and once again become an equity market that foreign investors want to own.

Source: Saxo Group

Abenomics launched in December 2012 started a revival of the Japanese economy lifting inflation, economic growth, and women’s participation in the labour force. The following six years, corporate earnings among publicly listed companies rose 282% or 26% p.a. before a weakening global economy took Japanese earning down by 18% before the Covid-19 pandemic. Earnings are down 54% from the peak but they will come roaring back. Analysts expect earnings to jump 56% over the next 12 months and then 15% more in the following year. These estimates could prove conservative. As we wrote yesterday in our note on emerging markets, China will most likely ease financial conditions in 2021 lifting economic growth in China and Asia benefitting export-driven Japanese companies. But there is more to the Japanese miracle in equities than the usual pro-cyclical factors and Chinese growth.

Source: Bloomberg

If we exclude the destruction from the Covid-19 pandemic, Japanese companies have in general lifted their ROE back to the level before the financial crisis in 2008 indicating that Japanese companies are becoming more efficient and shareholder friendly. Several Japanese companies have been under attack by US activist funds forcing them to get rid of crossholdings and inefficient businesses while embracing share buybacks. The current low ROE reflects a crisis and with the rebound in earnings we will also see a rebound in Japanese ROE.

Source: Bloomberg

Japanese companies also operate with a much lower net-debt-to-EBITDA (financial leverage), which means that Japanese will do relatively better than US, Chinese and European companies if interest rates or inflation rise in the coming years. Maybe that is what investors are beginning to recognise? On top of that, Japanese companies have very high capital expenditures and R&D level compared to the world paving the path to higher growth in the future. The Japanese equity market also gives exposure to automation and robotics companies which is one of the mega trends in the coming decades. Finally, Japanese equities are trading at a 17% discount to the global equity market on a 12-month basis.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
Most of our staff in Singapore are working from home to help limit the spread of the coronavirus. We remain at your service on the details below. Thank you for your understanding.

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.